probenecid has been researched along with Enterovirus Infections in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Enterovirus Infections: Diseases caused by ENTEROVIRUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sethy, B | 1 |
| Hsieh, CF | 1 |
| Yeh, C | 1 |
| Horng, JT | 1 |
| Hsieh, PW | 1 |
1 other study available for probenecid and Enterovirus Infections
| Article | Year |
|---|---|
Design, synthesis & structure-activity relationships of a new class of antihuman enterovirus D68 & A71 agents.
Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Drug Design; Drug Evaluation, Preclinical; Drug | 2018 |